Bicarbonate therapy and intracellular acidosis

The use of sodium bicarbonate to treat metabolic acidosis remains a topic of debate. Some studies suggest that extracellular alkalinization may lead to unintended intracellular acidification. This phenomenon, known as 'paradoxical' acidosis, is thought to arise from shifts in carbon dioxide and bicarbonate equilibrium across cell membranes. Prior research has shown that intracellular pH can be affected by changes in extracellular pH. However, the clinical relevance of these findings is unclear. Experimental models have used in vitro systems to explore how sodium bicarbonate influences intracellular pH. These studies often involve manipulating extracellular conditions to mimic acidotic states. Some findings suggest that large doses of bicarbonate may cause intracellular acidification. Yet, the extent of this effect under conditions resembling clinical practice has not been fully established. This gap motivated the current investigation into the relationship between sodium bicarbonate administration and intracellular pH changes.

This study aimed to evaluate how sodium bicarbonate affects intracellular pH in human leucocytes under controlled in vitro conditions. The researchers sought to determine whether the observed intracellular acidification is significant enough to question bicarbonate therapy in clinical settings. They focused on the impact of varying sodium bicarbonate concentrations and administration methods. The study also examined how initial intracellular pH levels influence the response to bicarbonate. By simulating metabolic acidosis with lactic and propionic acid, the researchers aimed to mimic clinical scenarios. The goal was to assess whether the acidification effect is clinically relevant or merely an in vitro artifact. They also investigated whether small, incremental doses of bicarbonate reduce the risk of intracellular acidosis. Ultimately, the study aimed to provide evidence to inform the ongoing debate on the safety and efficacy of bicarbonate therapy.

The researchers used a fluorescent intracellular pH dye to monitor changes in leucocyte suspensions from healthy volunteers. They varied the concentration of sodium bicarbonate added to the extracellular buffer. Lactic and propionic acids were introduced to simulate metabolic acidosis conditions. The study compared the effects of a single large dose of bicarbonate versus multiple small doses. Intracellular pH shifts were measured in response to these interventions. The initial intracellular pH was also manipulated to assess its influence on the outcome. The experimental setup allowed for precise control of extracellular pH and bicarbonate levels. The results were analyzed to determine the relationship between administration method, dose size, and intracellular pH changes.

The addition of a large bolus of sodium bicarbonate caused intracellular acidification, as previously reported. This effect was most pronounced at higher initial intracellular pH levels. When bicarbonate was administered in small, incremental doses, the intracellular pH change was minimal. Under conditions of initial acidosis, intracellular pH rapidly increased after bicarbonate addition. The extent of acidification was dose-dependent and influenced by the starting pH of the cells. The researchers observed that the acidification effect was transient and not sustained over time. The study found that the observed changes in intracellular pH were small when conditions resembled clinical practice. These findings suggest that the acidification effect may not be clinically significant in real-world scenarios.

The authors suggest that the observed intracellular acidification following bicarbonate administration is minimal under conditions resembling clinical practice. They argue that the transient and small pH changes do not provide sufficient grounds to abandon bicarbonate therapy in human acidosis. The study highlights that the effect is most noticeable at higher initial intracellular pH levels. The administration method significantly influences the outcome, with small doses reducing the risk of acidification. The researchers propose that the clinical relevance of the observed phenomenon is limited. They emphasize that the acidification effect is not sustained and does not appear to be a major concern in real-world settings. The findings support the continued use of sodium bicarbonate in treating metabolic acidosis. The authors conclude that the evidence does not strongly suggest that bicarbonate therapy should be avoided due to intracellular acidification.